成年人戒烟 - 美国,2022年
MMWR. Morbidity and mortality weekly report
|July 25, 2024
概括
大多数美国成年吸烟者都想戒烟,并试图这样做,但很少有人成功. 医疗保健提供者的支持和基于证据的戒烟治疗对于提高成功戒烟率至关重要.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 行为科学 行为科学
背景情况:
- 烟草成是一种由尼古丁成驱动的慢性疾病.
- 医疗保健提供者的干预措施和基于证据的治疗方法可以提高戒烟的成功率.
- 了解国家戒烟指标对于公共卫生倡议至关重要.
研究的目的:
- 评估2022年美国成年人戒烟指标的全国估计.
- 根据薄荷香烟的使用,检查戒烟兴趣,尝试和成功的差异.
- 确定改善戒烟服务和支持的机会.
主要方法:
- 分析了2022年国家卫生访谈调查 (NHIS) 的数据.
- 计算了戒烟兴趣,戒烟尝试,戒烟成功以及接受卫生专业人士建议/协助的流行率.
- 在薄荷香烟和非薄荷香烟吸烟者之间进行了比较.
主要成果:
- 在2022年,67.7%的成年吸烟者想戒烟,53.3%试图戒烟,8.8%成功戒烟.
- 约一半的吸烟者看到了医疗专业人员获得了建议 (50.5%) 或帮助 (49.2%) 戒烟.
- 与非薄荷醇吸烟者相比,薄荷醇吸烟者表现出更高的戒烟兴趣和尝试,但与非薄荷醇吸烟者相比,咨询和治疗使用率较低,戒烟成功率相似.
结论:
- 通过公共卫生和医疗保健部门,有显著的机会来加强戒烟.
- 建议扩大对戒烟服务和支持的获取和使用.
- 公平的戒烟策略对于推动所有人口群体戒烟至关重要.
更多相关视频
06:39Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
Published on: August 28, 2017
14.3K
06:12Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition
Published on: March 3, 2023
737
相关概念视频
Stimulants
181
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
181
Stress Prevention and Stress Management Techniques IV
28
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
28
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
CNS Depressants: Alcohol and Nicotine
193
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
193
Statistical Methods for Analyzing Epidemiological Data
344
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
344
Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K
